HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission.

AbstractBACKGROUND:
The drug of choice for leishmaniasis is pentavalent antimony and different regimens are under continuous evaluation. The ideal therapy should be simple, effective, and with no or minor side-effects. In this paper we have studied the efficacy of intralesionally applied antimony in New World cutaneous leishmaniasis.
METHODS:
Seventy-four patients from Rio de Janeiro state, Brazil, and presenting with single ulcerative cutaneous lesions mainly located on the trunk or extremities were enrolled in the study. The drug employed was N-methyl glucamine (425 mg of Sbv in each 5 ml ampoule). Each lesion was infiltrated with the drug at the four cardinal points in order to achieve complete blanching.
RESULTS:
Of the 74 patients, 59 (80%) were healed after a 12-week interval. Extensive follow-up (up to 10 years) disclosed no relapses or the development of mucosal lesions.
CONCLUSIONS:
The aim of therapy in New World cutaneous leishmaniasis is the healing of the cutaneous lesion and the prevention of late mucosal damage. Both conditions were achieved with the treatment employed with no side-effects and a considerable decrease in costs. In addition, the method is easy to apply in the field.
AuthorsM P Oliveira-Neto, A Schubach, M Mattos, S C da Costa, C Pirmez
JournalInternational journal of dermatology (Int J Dermatol) Vol. 36 Issue 6 Pg. 463-8 (Jun 1997) ISSN: 0011-9059 [Print] England
PMID9248897 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiprotozoal Agents
  • antimony-N-methylglucamine
  • Meglumine
  • Antimony
Topics
  • Adult
  • Animals
  • Antimony (administration & dosage, economics, therapeutic use)
  • Antiprotozoal Agents (administration & dosage, economics, therapeutic use)
  • Brazil
  • Costs and Cost Analysis
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intralesional
  • Leishmania braziliensis
  • Leishmaniasis, Cutaneous (drug therapy, transmission)
  • Male
  • Meglumine (administration & dosage, analogs & derivatives, economics, therapeutic use)
  • Recurrence
  • Remission Induction
  • Skin Ulcer (drug therapy, parasitology)
  • Treatment Outcome
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: